Advagene Biopharma Co., Ltd. (6709.TWO)

TWD 19.7

(-0.51%)

Annual Balance Sheets

(In TWD)
Breakdown 2023 2022 2021 2020 2019
Total Assets 147.93 Million 140.83 Million 260.4 Million 316.25 Million 279.21 Million
Total Current Assets 146.41 Million 125.81 Million 243.99 Million 294.14 Million 257.28 Million
Cash And Short Term Investments 125.19 Million 103 Million 223.83 Million 273.49 Million 238 Million
Cash and Cash Equivalents 65.19 Million 18 Million 14.33 Million 121.89 Million 12.3 Million
Short Term Investments 60 Million 85 Million 209.5 Million 151.6 Million 174.8 Million
Net Receivables 92 Thousand - - - -
Inventory -91.99 Thousand - - - -
Other Current Assets 21.22 Million 22.8 Million 20.16 Million 42.25 Million 70.18 Million
Total Non-Current Assets 1.52 Million 15.02 Million 16.41 Million 22.11 Million 21.93 Million
Net PPE 1.03 Million 3.22 Million 5.4 Million 7.9 Million 3.03 Million
Good Will And Intangible Assets - 9.81 Million 9.02 Million 13.72 Million 18.44 Million
Good Will - - - - -
Intangible Assets - 9.81 Million 9.02 Million 13.72 Million 18.44 Million
Long-Term Investments - - - - -
Tax Assets - - - - -
Other Non Current Assets 484 Thousand 1.98 Million 1.98 Million 484 Thousand 450 Thousand
Other Assets - - - - -
Total Liabilities 7.97 Million 9.07 Million 10.83 Million 16.93 Million 7.85 Million
Total Current Liabilities 7.97 Million 8.42 Million 8.27 Million 12.53 Million 7.85 Million
Account Payables 870 Thousand 561 Thousand 561 Thousand 562 Thousand 522 Thousand
Tax Payables - - - - -
Short Term Debt 870 Thousand 1.91 Million 1.83 Million 1.79 Million -
Deferred Revenue -870 Thousand -561 Thousand -561 Thousand -562 Thousand -
Other Current Liabilities 7.1 Million 6.5 Million 6.43 Million 10.74 Million 7.33 Million
Total Non Current Liabilities - 653 Thousand 2.56 Million 4.39 Million -
Long-Term Debt - 653 Thousand 2.56 Million 4.39 Million -
Deferred Revenue Non Current - - - - -
Deferred Tax Liabilities Non Current - - - - -
Other Non Current Liabilities - - - - -
Other Liabilities - - - - -
Total Equity 139.96 Million 131.76 Million 249.56 Million 299.32 Million 271.36 Million
Stock Holders Equity 139.96 Million 131.76 Million 249.56 Million 299.32 Million 271.36 Million
Common Stock 533.8 Million 493.49 Million 492.92 Million 541.99 Million 443.87 Million
Retained Earnings -454.22 Million -364.85 Million -338.47 Million -247.72 Million -253.41 Million
Accumulated other comprehensive income - - - 96.56 Million -
Common Stock Equity 139.96 Million 131.76 Million 249.56 Million 299.32 Million 271.36 Million
Capital Lease Obligation - 2 Million 3.83 Million 5.62 Million -
Total Investments 60 Million 85 Million 209.5 Million 151.6 Million 174.8 Million
Total Debt 870 Thousand 2.56 Million 4.4 Million 6.18 Million -
Net Debt -64.32 Million -15.44 Million -9.93 Million -115.7 Million -12.3 Million

Balance Sheet Charts